Codice QR

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse ev...

Descrizione completa

Salvato in:
Autori principali: Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2025-04-01
Serie:ESC Heart Failure
Soggetti:
Immune‐checkpoint inhibitor
Cardio‐oncology
ICI‐related myocarditis
Accesso online:https://doi.org/10.1002/ehf2.15131
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi